Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex322_6.htm |
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex321_7.htm |
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex312_8.htm |
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex311_9.htm |
EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex231_1020.htm |
EX-10.14 - EX-10.14 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex1014_989.htm |
10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC. | alny-10k_20161231.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
|
|
|
|
|
Name |
|
Ownership Percentage |
|
Jurisdiction of Organization |
Alnylam U.S., Inc. |
|
100% |
|
Delaware |
Alnylam Securities Corporation |
|
100% |
|
Massachusetts |
Sirna Therapeutics, Inc. |
|
100% |
|
Delaware |
Alnylam (Bermuda) Ltd. |
|
100% |
|
Bermuda |
Alnylam France S.A.S |
|
100% |
|
France |
Alnylam Europe AG |
|
100% |
|
Germany |
Alnylam Germany GmbH |
|
100% |
|
Germany |
Alnylam Italy S.r.l. |
|
100% |
|
Italy |
Alnylam Sweden AB |
|
100% |
|
Sweden |
Alnylam Switzerland GmbH |
|
100% |
|
Switzerland |
Alnylam UK Limited |
|
100% |
|
United Kingdom |